🔴 Pyxis Oncology is trading 10.34% down in pre-market after pricing a $110 million offering with warrants

Pyxis Oncology is trading at $2.60, down 10.34%, after pricing a public offering expected to raise approximately $110 million before offering expenses.

• The offering is priced at $2.90 per share with an accompanying warrant, above the supplied pre-market price.
• It includes about 36.0 million shares (or pre-funded warrants) and warrants to purchase about 49.3 million shares at $3.50 each.